Author:
Bloch Michael H.,Wasylink Suzanne,Landeros-Weisenberger Angeli,Panza Kaitlyn E.,Billingslea Eileen,Leckman James F.,Krystal John H.,Bhagwagar Zubin,Sanacora Gerard,Pittenger Christopher
Funder
National Institutes of Health
National Center for Research Resources
NIH
National Center for Research Resources to Yale University
AstraZeneca
Bristol-Myers-Squibb
Hoffman La-Roche
Merck & Compay
Sunovion
Reference44 articles.
1. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder;Foa;Am J Psychiatry,2005
2. A systematic review: Antipsychotic augmentation with treatment refractory obsessive-compulsive disorder;Bloch;Mol Psychiatry,2006
3. Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder;Bloch;Mol Psychiatry,2010
4. Effectiveness of antidepressants;Bollini;Br J Psychiatry,1999
5. Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment;Pittenger;Pharmacol Ther,2011
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献